Daniele Rossini
0000-0002-6114-7335
4 papers found
Refreshing results…
An immune-related gene expression signature predicts benefit from adding atezolizumab to FOLFOXIRI plus bevacizumab in metastatic colorectal cancer
Treatments after first progression in metastatic colorectal cancer. A literature review and evidence-based algorithm
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib
Merkel Cell Carcinoma of the Retroperitoneum with No Identifiable Primary Site
Missing publications? Search for publications with a matching author name.